ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 218 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,787,166 | -27.5% | 848,441 | -17.6% | 0.02% | -30.3% |
Q1 2024 | $19,029,594 | +119.4% | 1,029,183 | +271.5% | 0.03% | +106.2% |
Q4 2023 | $8,674,498 | +161.8% | 277,052 | +74.2% | 0.02% | +100.0% |
Q3 2023 | $3,313,810 | -19.4% | 159,012 | -27.2% | 0.01% | -52.9% |
Q1 2023 | $4,112,735 | -47.2% | 218,530 | -54.1% | 0.02% | -56.4% |
Q3 2022 | $7,786,000 | +11.7% | 475,921 | -3.8% | 0.04% | 0.0% |
Q2 2022 | $6,970,000 | +44.2% | 494,702 | +147.8% | 0.04% | +85.7% |
Q1 2022 | $4,835,000 | +579.1% | 199,623 | +554.7% | 0.02% | +950.0% |
Q4 2021 | $712,000 | -62.9% | 30,491 | -73.6% | 0.00% | -66.7% |
Q3 2021 | $1,919,000 | +10.0% | 115,550 | +254.3% | 0.01% | -53.8% |
Q4 2020 | $1,744,000 | -79.8% | 32,616 | -84.4% | 0.01% | -88.9% |
Q3 2020 | $8,649,000 | +169.8% | 209,673 | +217.0% | 0.12% | +125.0% |
Q2 2020 | $3,206,000 | -4.4% | 66,139 | -16.6% | 0.05% | -39.5% |
Q1 2020 | $3,352,000 | -66.2% | 79,336 | -65.8% | 0.09% | +45.8% |
Q4 2019 | $9,923,000 | +258.2% | 231,957 | +201.4% | 0.06% | +136.0% |
Q3 2019 | $2,770,000 | +522.5% | 76,955 | +179.4% | 0.02% | +400.0% |
Q4 2018 | $445,000 | -57.5% | 27,541 | -45.3% | 0.01% | -61.5% |
Q3 2018 | $1,046,000 | -31.5% | 50,364 | -25.9% | 0.01% | -45.8% |
Q1 2018 | $1,527,000 | -32.9% | 67,965 | -10.1% | 0.02% | -40.0% |
Q4 2017 | $2,277,000 | +81.7% | 75,613 | +127.4% | 0.04% | +66.7% |
Q3 2017 | $1,253,000 | -44.4% | 33,256 | -49.3% | 0.02% | -61.3% |
Q1 2017 | $2,255,000 | -5.6% | 65,586 | -10.9% | 0.06% | -58.4% |
Q2 2016 | $2,389,000 | +551.0% | 73,600 | +614.6% | 0.15% | +272.5% |
Q4 2015 | $367,000 | – | 10,300 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |